Member AUM
$95 trillion

Welcome back

Return to main site

Animal Pharmaceuticals Engagement

View engagement

Overview:

Key Information

Current Year
2025/26
Current Phase
Phase 3
Current Stage
Company assessment and progress evaluation
Status
Closed
Theme
Antibiotics & Health
GICS Sub-industries
Pharmaceuticals
Main Contact(s)
Emma Berntman PhD

Companies:

Engagement downloads:

Aug
2024

Health and Wealth: The Investors’ Guide to Antimicrobial Resistance (AMR)

May
2024

From Farms to Forks: Antibiotic Stewardship in the Animal Pharmaceutical and Quick Service Restaurant Sectors

Nov
2023

Antibiotics in Aquaculture Factsheet

Nov
2023

Animal Pharmaceuticals - Investor Engagement Questions

Nov
2023

Antibiotics in Pigs & Poultry Factsheet

Nov
2023

Antibiotics in Beef & Dairy Industry Factsheet

May
2023

Investor Briefing Pack

May
2023

Animal Pharmaceuticals Engagement Progress Report Webinar Video

May
2023

Sample Engagement Letter

May
2023

Key Findings Report

May
2023

Progress Report

Jul
2021

Feeding Resistance | Summary Report

Jul
2021

Feeding Resistance | Members' Report